Industry News (Joint Venture)

Research Partnership Announced To Develop HIV Vaccines

Published in AIDS Weekly, December 14th, 1998

AlphaVax Human Vaccines Inc., Durham, North Carolina, has entered a $4.6 million research partnership with the International AIDS Vaccine Initiative (IAVI).

The AlphaVax research team is one of two groups chosen by IAVI to accelerate AIDS vaccine development. The other team is based in Oxford, United Kingdom. IAVI's total funding commitment of $9.1 million represents the two single largest AIDS research awards ever by a non-governmental organization, IAVI said in a news release.

The AlphVax team is led by Robert Olmsted, PhD, and Robert Johnston, PhD, Durham, North Carolina. AlphaVax plans to collaborate with the University of Capetown in South...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of AIDS Weekly

Source: AIDS Weekly (1998-12-14)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry